Retinoic acid and affective disorders: the evidence for an association
JD Bremner, KD Shearer… - The Journal of clinical …, 2011 - psychiatrist.com
Objective: Isotretinoin (13-cis-retinoic acid), approved by the US Food and Drug
Administration for the treatment of acne, carries a black box warning related to the risk of …
Administration for the treatment of acne, carries a black box warning related to the risk of …
[HTML][HTML] Psychiatric and developmental effects of isotretinoin (retinoid) treatment for acne vulgaris
A Suuberg - Current Therapeutic Research, 2019 - Elsevier
Background An association between isotretinoin (13-cis-retinoic acid, sold under trade
names including Accutane [Hoffmann-La Roche Inc, Basel, Switzerland]) and birth defects …
names including Accutane [Hoffmann-La Roche Inc, Basel, Switzerland]) and birth defects …
The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system
J Shin, TC Cheetham, L Wong, F Niu, E Kass… - Journal of the American …, 2011 - Elsevier
BACKGROUND: Preventing fetal exposure to isotretinoin is widely acknowledged as an
important safety issue. The iPLEDGE program is the latest in a series of Food and Drug …
important safety issue. The iPLEDGE program is the latest in a series of Food and Drug …
Isotretinoin updates
SCJ On, J Zeichner - Dermatologic Therapy, 2013 - Wiley Online Library
Acne vulgaris is a chronic inflammatory disease of pilosebaceous follicles commonly
affecting adolescents and young adults. This disease has a profound psychological impact …
affecting adolescents and young adults. This disease has a profound psychological impact …
Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy …
M Teichert, LE Visser, M Dufour, E Rodenburg… - Drug safety, 2010 - Springer
Background: Isotretinoin is very effective in the treatment of severe acne. However, because
of the teratogenic properties of this agent an isotretinoin Pregnancy Prevention Programme …
of the teratogenic properties of this agent an isotretinoin Pregnancy Prevention Programme …
Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey
ET Landis, MM Levender, SA Davis… - Journal of …, 2012 - Taylor & Francis
Objective: To determine whether oral contraceptives (OCPs) are underutilized in the
treatment of acne in women of reproductive age, how use of OCPs compares with use of …
treatment of acne in women of reproductive age, how use of OCPs compares with use of …
Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential
Background Potent teratogenicity limits the use of isotretinoin among females of
childbearing potential (FCBP). Objective To explore the current practice of dermatologists for …
childbearing potential (FCBP). Objective To explore the current practice of dermatologists for …
[HTML][HTML] Systemic isotretinoin treatment and pregnancy: a longitudinal cohort study from Turkey
S Ozyurt, AF Kaptanoglu - The Eurasian journal of medicine, 2015 - ncbi.nlm.nih.gov
Objective: Isotretinoin is known to be the most effective treatment of severe and persistent
acne. However, one of the most important adverse effects of this drug is known to be …
acne. However, one of the most important adverse effects of this drug is known to be …
Skin in the game: Comparing the private and public regulation of Isotretinoin
RJ March - Journal of Institutional Economics, 2017 - cambridge.org
This paper engages in a comparative-institutional analysis of the private and public risk-
management programs of the drug isotretinoin, which are designed to prevent the undesired …
management programs of the drug isotretinoin, which are designed to prevent the undesired …
Physician performance measures in dermatology
RL Wilson, SR Feldman - Journal of the American Academy of Dermatology, 2010 - Elsevier
Performance measures serve as a method of assessing and reporting on the quality of care
that physicians are delivering to their patients. Although measures have been developed …
that physicians are delivering to their patients. Although measures have been developed …